Marc Frahm

Stock Analyst at TD Cowen

(0.10)
# 4,141
Out of 4,820 analysts
16
Total ratings
15.38%
Success rate
-33.91%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Marc Frahm

Sana Biotechnology
Jan 8, 2025
Upgrades: Buy
Price Target: n/a
Current: $1.76
Upside: -
Theravance Biopharma
Aug 6, 2024
Maintains: Hold
Price Target: $10$9
Current: $9.74
Upside: -7.60%
Incyte
May 1, 2024
Maintains: Buy
Price Target: $88$80
Current: $59.53
Upside: +34.39%
Cullinan Therapeutics
Jun 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $7.75
Upside: -
Xilio Therapeutics
Nov 16, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.77
Upside: -
Nuvalent
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $75.20
Upside: -
Elevation Oncology
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.36
Upside: -
Janux Therapeutics
Jul 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $32.26
Upside: -
Day One Biopharmaceuticals
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.75
Upside: -
Inozyme Pharma
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.96
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $1.60
Upside: -